Pharming Group N.V.
PHAR
$13.96
$0.5594.17%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 485.39% | 191.55% | -192.34% | -1.97% | |
| Total Depreciation and Amortization | 1,022.18% | 3.70% | -109.27% | 156.76% | |
| Total Amortization of Deferred Charges | -- | -3.62% | -- | -- | |
| Total Other Non-Cash Items | 336.58% | -19.04% | 84.15% | 89.33% | |
| Change in Net Operating Assets | 85.03% | -411.92% | -876.99% | 91.42% | |
| Cash from Operations | 188.82% | -19.40% | -37.42% | 66.44% | |
| Capital Expenditure | 40.19% | 57.24% | 72.24% | 62.79% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -53.34% | -168.04% | 155.24% | -- | |
| Cash from Investing | -53.41% | -150.51% | 154.29% | 408.84% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 99.21% | -693.72% | -10,640.14% | 21.19% | |
| Issuance of Common Stock | -59.43% | 727.67% | -- | 27.19% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -377.66% | -157.12% | 15.24% | -15.30% | |
| Cash from Financing | 90.26% | -116.08% | -976.61% | 6.05% | |
| Foreign Exchange rate Adjustments | 1,489.76% | -795.90% | 181.58% | -112.87% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 773.64% | -180.67% | 94.04% | 56.35% | |